AZRX - AzurRx BioPharma, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts3333
Avg. Estimate-0.11-0.12-0.54-0.42
Low Estimate-0.13-0.15-0.64-0.58
High Estimate-0.09-0.1-0.47-0.31
Year Ago EPS-0.25-0.17-0.68-0.54
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts1121
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20199/29/201912/30/20193/30/2020
EPS Est.-0.21-0.16-0.16-0.12
EPS Actual-0.25-0.17-0.05-0.2
Difference-0.04-0.010.11-0.08
Surprise %-19.00%-6.30%68.80%-66.70%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.11-0.12-0.54-0.42
7 Days Ago-0.11-0.12-0.54-0.42
30 Days Ago-0.12-0.12-0.53-0.44
60 Days Ago-0.13-0.13-0.51-0.53
90 Days Ago-0.12-0.13-0.48-0.49
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1N/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesAZRXIndustrySectorS&P 500
Current Qtr.56.00%N/AN/AN/A
Next Qtr.29.40%N/AN/AN/A
Current Year20.60%N/AN/AN/A
Next Year22.20%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A